keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BT1718 is a bicyclic peptide conjugate that targets MT1-MMP, a protease overexpressed in various advanced solid tumors such as triple-negative breast cancer (TNBC) and non-small cell lung cancer [1] [2]. By exploiting MT1-MMP, BT1718 delivers its cytotoxic payload, Mertansine, with a strong affinity characterized by a dissociation constant (K D) of 3 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | BT1718 is a bicyclic peptide conjugate that targets MT1-MMP, a protease overexpressed in various advanced solid tumors such as triple-negative breast cancer (TNBC) and non-small cell lung cancer [1] [2]. By exploiting MT1-MMP, BT1718 delivers its cytotoxic payload, Mertansine, with a strong affinity characterized by a dissociation constant (K D) of 3 nM. |
In vitro | BT1718 (IC50 = 1 nM, 72 h) demonstrated cytotoxicity against HT-1080 cells in an ATP endpoint assay [2]. |
In vivo | BT1718 (10mg/kg, intravenous injection, thrice weekly) demonstrated rapid tumor clearance in a mouse xenograft model derived from EBC-1 cells positive for MT1 [2]. Furthermore, with once or twice weekly intravenous administration of BT1718 at the same dosage, complete tumor eradication was observed in a mouse xenograft model implanted with MT1 positive HT-1080 cells [2]. |
Molecular Weight | N/A |
Formula | C159H218ClN31O47S5 |
CAS No. | 2227366-66-5 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BT1718 2227366-66-5 Proteases/Proteasome MMP inhibitor inhibit